Citius Oncology Inc [NASDAQ: CTOR] gained 43.14% on the last trading session, reaching $1.46 price per share at the time.
If compared to the average trading volume of 214.36K shares, CTOR reached a trading volume of 101583996 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Citius Oncology Inc [CTOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CTOR shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CTOR stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Citius Oncology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 27, 2024.
Trading performance analysis for CTOR stock
Citius Oncology Inc [CTOR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 71.74. With this latest performance, CTOR shares gained by 28.07% in over the last four-week period, additionally sinking by -86.86% over the last 6 months – not to mention a drop of -85.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CTOR stock in for the last two-week period is set at 61.74, with the RSI for the last a single of trading hit 73.03, and the three-weeks RSI is set at 51.34 for Citius Oncology Inc [CTOR]. The present Moving Average for the last 50 days of trading for this stock 1.1575, while it was recorded at 1.0670 for the last single week of trading, and 7.6854 for the last 200 days.
Citius Oncology Inc [CTOR]: A deeper dive into fundamental analysis
Citius Oncology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.01 and a Current Ratio set at 0.01.
